Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 4
2008 6
2009 2
2010 1
2011 7
2012 4
2013 8
2014 10
2015 5
2016 5
2017 3
2018 2
2019 4
2020 8
2021 3
2022 2
2023 5
2024 4
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.
Collins DM, Madden SF, Gaynor N, AlSultan D, Le Gal M, Eustace AJ, Gately KA, Hughes C, Davies AM, Mahgoub T, Ballot J, Toomey S, O'Connor DP, Gallagher WM, Holmes FA, Espina V, Liotta L, Hennessy BT, O'Byrne KJ, Hasmann M, Bossenmaier B, O'Donovan N, Crown J. Collins DM, et al. Among authors: gately ka. Clin Cancer Res. 2021 Feb 1;27(3):807-818. doi: 10.1158/1078-0432.CCR-20-2007. Epub 2020 Oct 29. Clin Cancer Res. 2021. PMID: 33122343 Free PMC article. Clinical Trial.
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.
Pirker R, Herth FJ, Kerr KM, Filipits M, Taron M, Gandara D, Hirsch FR, Grunenwald D, Popper H, Smit E, Dietel M, Marchetti A, Manegold C, Schirmacher P, Thomas M, Rosell R, Cappuzzo F, Stahel R; European EGFR Workshop Group. Pirker R, et al. J Thorac Oncol. 2010 Oct;5(10):1706-13. doi: 10.1097/JTO.0b013e3181f1c8de. J Thorac Oncol. 2010. PMID: 20871269 Free article.
Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma.
Lewis F, Beirne J, Henderson B, Norris L, Cadoo K, Kelly T, Martin C, Hurley S, Kanjuga M, O'Driscoll L, Gately K, Oner E, Saini VM, Brooks D, Selemidis S, Kamran W, Haughey N, Maguire P, O'Gorman C, Saadeh FA, Ward MP, O'Leary JJ, O'Toole SA. Lewis F, et al. Among authors: gately k. Cancer Lett. 2024 Nov 28;605:217279. doi: 10.1016/j.canlet.2024.217279. Epub 2024 Sep 26. Cancer Lett. 2024. PMID: 39341451 Free article. Review.
Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer.
O'Sullivan É, Keogh A, Henderson B, Finn SP, Gray SG, Gately K. O'Sullivan É, et al. Among authors: gately k. Cancers (Basel). 2023 Mar 7;15(6):1635. doi: 10.3390/cancers15061635. Cancers (Basel). 2023. PMID: 36980522 Free PMC article. Review.
Thymidine Phosphorylase in Cancer; Enemy or Friend?
Elamin YY, Rafee S, Osman N, O Byrne KJ, Gately K. Elamin YY, et al. Among authors: gately k. Cancer Microenviron. 2016 Apr;9(1):33-43. doi: 10.1007/s12307-015-0173-y. Epub 2015 Aug 23. Cancer Microenviron. 2016. PMID: 26298314 Free PMC article. Review.
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Luszczak S, Kumar C, Sathyadevan VK, Simpson BS, Gately KA, Whitaker HC, Heavey S. Luszczak S, et al. Among authors: gately ka. Signal Transduct Target Ther. 2020 Jan 31;5(1):7. doi: 10.1038/s41392-020-0109-y. Signal Transduct Target Ther. 2020. PMID: 32296034 Free PMC article. Review.
Targeting the fibroblast growth factor receptor family in cancer.
Hallinan N, Finn S, Cuffe S, Rafee S, O'Byrne K, Gately K. Hallinan N, et al. Among authors: gately k. Cancer Treat Rev. 2016 May;46:51-62. doi: 10.1016/j.ctrv.2016.03.015. Epub 2016 Apr 12. Cancer Treat Rev. 2016. PMID: 27109926 Review.
82 results